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lights at other drivers, slowing down in front of drivers who are tailgating, and cutting
off other drivers). Most participants reported engaging in more passive behaviors,
such as shaking their heads at other drivers.

Statistics
FINDING AN OPTIMAL DESIGN USING PSEUDOFACTORS. Mary A.
Marion, Department of Statistics, Virginia Polytechnic Institute and State University.
This paper was written as a result of an Industrial Systems Engineering project
performed at Virginia Tech. This paper reflects an evolving procedure to design an
industrial experiment utilizing optimality criteria, AIC statistic and the usual
regression/ANOVA model statistics. Discrete factor settings were coded as
continuous to utilize response surface methods to find the best settings to reach a
specified target. While the industrial example is trivial the characteristics of the
project lend themselves to illustrate the complexity of real life applications.
AN INCREMENTAL FORWARD STAGEWISE REGRESSION ALGORITHM
FOR DICHOTOMOUS RESPONSE VARIABLES. Adam Sima, Department of
Biostatistics, Virginia Commonwealth University. The Incremental Forward
Stagewise Regression (IFSR) procedure was developed by Hastie, et al. (2001) as a
flexible estimation procedure for fitting penalized linear models. To generalize this
procedure, the IFSR estimation method was extended for use with a dichotomous
response variable. In particular, a simulation study was used compare both the
accuracy in prediction and model fit to similar algorithms that simultaneously fit a
model and estimate parameters. The results show that this method is comparable to
some commonly used algorithms.
INTRODUCTION TO DISCRETE CHOICE MODELS. Bhaskara S. Ravi and N.
Rao Chaganty, Department of Mathematics and Statistics, Old Dominion University.
We often encounter with decisions that involve choosing between alternatives or
choices such as “which phone to buy” or “which minute plan” to choose or “which
brand of shampoo to buy” etc. Interestingly, these decisions not only depend on
individual characteristics but heavily on alternatives available. Discrete choice
models analyze such choice behavior and these are very popular in economics. This
talk aims at introducing very famous McFadden’s conditional logit model and the
importance of IIA (Independence of irrelevant attributes) assumption. Also, a
review of current trends and challenges in this popular research area are presented.

Structural Biology, Biochemistry and Biophysics
MECHANISM OF ACTION OF UDP-GALACTOPYRANOSE MUTASE FROM
TRYPANOSOMA CRUZI. Michelle Oppenheimer, Ana L. Valenciano, Jun Qi, &
Pablo Sobrado, Department of Biochemistry, Virginia Tech, Blacksburg, VA
24061. Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas’ disease,
which if untreated leads to chronic inflammation of the heart. UDP-galactopyranose
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mutase (UGM) is a flavoenzyme that catalyzes the conversion of
UDP-galactopyranose (UDP-Galp) to UDP-galactofuranose (UDP-Galf). UGM are
important in parasitic pathogenesis and are absent in mammals, making UGM an
attractive drug target. The chemical mechanism of UGM is not well understood. We
have used steady-state kinetics, rapid-reaction kinetics, and trapping intermediates to
better understand the mechanism of function of UGM. A kcat value of 8.1 ± 0.3 and a
KM value of 43 ± 7 µM were determined for T. cruzi UGM (TcUGM) using
steady-state kinetics. Spectral change indicative of a predicted flavin iminium ion
were detected by rapid reaction kinetics analyses, consistant with a postulated flavin
galactose adduct. The intermediate forms at a rate of 310 ± 40 s-1, suggesting this is
not the rate limiting step. We have trapped this intermediate and have been able to
isolate the adduct by both the HPLC and identify it by mass spectrometry. Lastly, We
sought to determine the redox partner for TcUGM. We show that TcUGM can be
reduced by NAD(P)H and maintained the reduced state for several catalytic cycles.
This activity is unique to eukaryotic UGMs as prokaryotic UGMs do not react with
NAD(P)H. Supported by NIH grants GM094469 and AI082542 and the American
Heart Association.
PROBING THE MECHANISM OF HIGH-FIDELITY DNA SYNTHESIS USING
X-RAY CRYSTALLOGRAPHY. Eugene Wu, Department of Biology, University
of Richmond, Richmond, VA. DNA polymerases replicate DNA with higher
fidelity than would be expected from free energy differences between
complementary and mismatched base pairs. One approach to studying replication
fidelity is to determine X-ray crystal structures of reaction intermediates and
polymerase complexes with mismatched base pairs. A crystal structure of a
guanosine:thymidine triphosphate mismatch in the active site of DNA polymerase I
from Bacillus stearothermophilus revealed a key intermediate conformation
between the “open” and “closed” conformations. The previously unknown “ajar”
conformation allows the template to interact with the incoming nucleoside
triphosphate and position it relative to the polymerase active site. Complementary
dNTPs advance past this conformation to a correctly aligned closed conformation
for catalysis, while mismatches are misaligned, leading to substrate release. Other
DNA polymerase I family enzymes share features important for the three-state
sorting mechanism and are expected to use thia mechanism. One homologue with
an altered active site sequence may show a preference for the ajar conformation.
This homologue’s crystal structure has been solved by multiwavelength anomalous
dispersion and may lead to confirmation of the three-state or new insights into
nucleotide selection by DNA polymerases.
INCORPORATION OF TAUTOMERISM INTO MOLECULAR MODELING;
PROGRESS IN DEVELOPING PYRROLE-BASED ANTI-TUBULIN AGENTS.
C. Da,1 G. E. Kellogg,1 N. Telang2 & J. Gupton2, 1Virginia Commonwealth
University, Richmond VA 23298-0540 2University of Richmond, Richmond VA
23173. Tautomerism is a commonly observed chemical phenomenon that involves
readily available structural changes of the positions of protons and double bonds.
However, alternative tautomeric forms are often ignored in many molecular
modeling applications. In docking, inaccuracy in predicting binding affinities can be
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related to the failure to consider all possible states including tautomeric states. We are
working to incorporate tautomerism into modeling tools based around HINT
(Hydropathic INTeractions). A preliminary version of the program has been
developed to apply a simple, straightforward algorithm to identify and enumerate
tautomeric forms. It is being used in an ongoing project of designing and developing
pyrrole-based anti-tubulin agents, to identify and evaluate potential tautomers, and to
build quantitative predictive models.
HIGH-THROUGHPUT ASSAY TO IDENTIFY INHIBITORS AGAINST
UDP-GALACTOPYRANOSE MUTASE (UGM) FROM ASPERGILLUS
FUMIGATUS. Jun Qi, Michelle Oppenheimer, & Pablo Sobrado, Department of
Biochemistry, Virginia Tech, Blacksburg, VA 24061.
The flavoenzyme
UDP-galactopyranose mutase (UGM) catalyzes the isomerization of
UDP-galactopyranose to UDP-galactofuranose, the biosynthetic precursor of
galactofuranose (Galf). Galf residues are essential components in the cell wall of
pathogens and play vital roles for their virulence. Thus inhibitors of UGM that block
the biosynthesis of Galf could lead to novel therapeutics. To date, no eukaryotic
UGM inhibitors and only a few prokaryotic UGM inhibitors have been reported. We
present the development of a high-throughput fluorescence polarization (FP) assay to
identify specific inhibitors of eukaryotic UGM from human pathogenic fungus
Aspergillus fumigatus. Our FP binding assay demonstrates that specific binding to
eukaryotic AfUGM were only obtained from UDP-TAMRA chromophores, and a
UDP-TAMRA chromophore with Kd value of 2.6±0.2 μM was selected as the
fluorescent probe in the high-throughput FP assay. The competitive binding assay
indicates that this UDP-TAMRA chromophore shares the same binding site with
UDP, a known UGM ligand that binds to the active site of UGM. The FP assay was
evaluated and displayed excellent Z′ factor (0.79±0.01) and good tolerance to DSMO.
Nine compounds were screened in this system, and one compound was identified as
AfUGM ligand. This compound was further confirmed to inhibit the activity of
AfUGM in AfUGM activity assay, indicating that the compounds identified by our FP
high-throughput screening system are inhibitors of AfUGM. Supported by a NIH
grant RO1-AI082542 (R. Tarleton PI).
HOMOLOGY MODELS OF C-C CHEMOKINE TYPE-5 RECEPTORS. ARE
BOUND WATERS IMPORTANT IN BINDING SITES OF MEMBRANE BOUND
RECEPTORS? Saheem A. Zaidi, Philip D. Mosier, Yan Zhang & Glen E. Kellogg,
Department of Medicinal Chemistry, Virginia Commonwealth University,
Richmond, VA 23298. HIV-1 uses two plasma membrane receptors, CD4 and a
co-receptor, to facilitate its entry into the target plasma membrane. Depending upon
the type of virus, this co-receptor can either be C-C chemokine receptor type-5
(CCR5) or C-X-C chemokine receptor type 4 (CXCR4). Studies suggest that CCR5
plays a dominant role in early stages of infection. Many allosteric antagonists of
CCR5 are known to inhibit fusion/entry process and subsequent infection of HIV-1.
In the present study we explored an allosteric binding site of CCR5 and the possible
role protein-bound water molecules may play in the interaction. A homology model
of CCR5 was built using recently crystallized CXCR4 as a template, followed by
virtual docking of maraviroc, a known allosteric antagonist. Mutagenesis studies
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from the literature agreed with the docking pose obtained. Possible protein-bound
water sites were generated and the antagonist was re-docked. According to our model
there are at least two important protein-bound waters. One of the bound waters forms
a hydrogen bond bridge between the ligand and the protein while the second bound
water is displaced due to ionic-bridge formation between the ligand and the protein,
and thus increasing the binding affinity due entropic gain resulting from disruption of
water network in the unliganded receptor.
ANALYSIS OF POST-TRANSLATIONAL MODIFICATIONS OF SIKE
FOLLOWING DOUBLE-STRANDED RNA STIMULATION. Charlotte F.
Roberts, James D. Marion, R. Jason Call and Jessica K. Bell, Department of
Biochemistry and Molecular Biology, Virginia Commonwealth University,
Richmond, VA 23298. The innate immune system is the body’s first line of defense
against infectious agents. Essential to this response are cellular mechanisms that
recognize, sequester and eradicate these invading organisms. Toll-like receptor 3
(TLR3), a pathogen recognition receptor, is stimulated by the viral genomic material
double stranded RNA (dsRNA). TLR3 stimulation initiates a signaling cascade that
leads to the production of type 1 interferon. Critical to this signaling pathway is a
kinase complex, NAP1 (NAK associated protein 1)-TBK1 (TANK Binding Kinase
1)-IKK (IB kinase epsilon), which leads to the phosphorylation of IRF3 (interferon
regulatory factor) and IRF7 and production of IFN. To control this activity, SIKE
(Suppressor of IKK) acts as a physiological inhibitor of IKK and TBK1 activity
through an undefined mechanism. The role of post-translation modifications to
control SIKE function was examined. FLAG-tagged SIKE DNA was transiently
transfected into HEK293 followed by dsRNA stimulation for 24 h. Cell lysates were
harvested, SIKE immunoprecipitated using anti-FLAG antibody agarose beads.
Immunoblot analysis showed serine phosphorylation state following dsRNA
stimulation. Using in vitro kinetic assays, TBK1 mediated SIKE phosphorylation.
These results suggest that upon pathway stimulation and TBK1 activation, TBK1
phosphorylates SIKE signaling SIKE’s release from the kinase complex. Funding
provided in part by the American Cancer Society.
SUPPRESSOR OF IKK-EPSILON IS A MIXED TYPE INHIBITOR OF THE
TYPE I INTERFERON RESPONSE. James D. Marion, Charlotte F. Roberts, R.
Jason Call, and Jessica K. Bell, Department of Biochemistry and Molecular Biology,
Virginia Commonwealth University, Richmond, VA 23298. Kinases act in
signaling pathways to propagate the cellular response by phosphorylation of specific
targets that trigger downstream events that alter the cell’s transcriptional program. To
control kinase activity, the cell has developed an intricate series of protein
interactions that are required for activation or mediate inhibition. In innate immunity,
viral-derived ligands activate innate immune receptors to initiate an anti-response
including production of type I interferons. Downstream of these receptors, a critical
kinase complex, NAP1 (NAK associated protein 1)-TBK1 (TANK Binding Kinase
1)-IKKe (IkB kinase epsilon) phosphorylates of the transcription factor, IRF3
(interferon regulatory factor) and IRF7, which leads to the production of IFN-beta. To
control this activity, SIKE (Suppressor of IKK-epsilon) acts as a physiological
inhibitor the kinase activity through an undefined mechanism. Our goal is to define
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the inhibitory mechanism of SIKE in the kinase reaction. Using an in vitro kinase
assay, the Michaelis constant for IRF3 phosphorylation was determined (5
micromolar). Upon addition of increasing concentrations of SIKE, a decrease in
Vmax for IRF3 phosphorylation was observed with minimal change in Km. Further
analysis showed that SIKE functioned as a mixed type inhibitor with an approximate
IC50 of 450 nM. The effect of SIKE phosphorylation on inhibitory function is
currently under study. Funding provided in part by the American Cancer Society.
STRUCTURE
BASED
PREDICTIVE
MODELS
FOR
PROTEIN
POST-TRANSLATIONAL MODIFICATIONS. M. Zhang1 , V. A. Yakovlev2, R.
B. Mikkelsen2 & G. E. Kellogg1, 1Department of Medicinal Chemistry and Institute
for Structural Biology and Drug Discovery, Virginia Commonwealth University,
Richmond, VA 23298 2Department of Radiation Oncology, Massey Cancer Center,
Virginia Commonwealth University, Richmond, VA 23298. Nitric oxide (NO) has
long been identified as a diffusible signaling molecule, but only until recent years had
gained prominence as an inducer of redox-based protein post-translational
modifications (PTMs). NO-dependent PTM is achieved, in a large part, through
cysteine S-nitrosylation, the covalent addition of the NO moiety to a reactive cysteine
thiol (other modes of action also exist, such as tyrosine nitration). Over the last
decade, the number of reported substrates for S-nitrosylation has grown
exponentially, and are shown to participate in a wide range of biological processes,
however, the precise mechanism of S-nitrosylation is still elusive, the only certainty
is that targeting of S-nitrosylation between proteins, and especially between Cys
residues within substrate proteins reflects the interactions of a number of
determinants of specificity. In an attempt to untangle these determinants, we have
developed computational methods to build models of protein post-translational
modifications based on 3D structural features, which have been successfully applied
to predict tyrosine nitration. In the current study, we are developing models that we
hope can accurately predict Cys S-nitrosylation. Preliminary analysis with 821
cysteines has proven to be promising, some interesting interactions between
structural features have been identified with a logistic regression model, and a much
simpler but more accurate model was built with a novel ant-colony algorithm.
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